FMC Corporation (FMC) reported second-quarter 2026 revenue of $867 million, down 17 percent from a year earlier, and a consolidated GAAP net loss of $187 million. The company reported a GAAP net loss of $1.49 per diluted share.
Adjusted EBITDA was $153 million, down 26 percent from the prior-year period, while GAAP cash from operations was $363 million. FMC lowered its full-year outlook, citing a more challenging macro environment, and said its board concluded the strategic review announced in February 2026.
- Revenue excluding India was $841 million, down 20 percent versus the second quarter of 2025, which included India.
- Organic revenue declined 22 percent for the quarter.
- Adjusted earnings per diluted share were $0.26, down 62 percent from the prior-year quarter.
- Full-year 2026 revenue excluding India is now expected to range from $3.50 billion to $3.70 billion.
- Full-year adjusted EBITDA guidance was lowered to $620 million to $680 million.
- Full-year adjusted EPS guidance was lowered to $1.19 to $1.49.
- Free cash flow guidance increased to $75 million to $225 million and includes a $200 million upfront licensing payment for rimisoxafen.
- FMC said actions including an India business sale agreement, a rimisoxafen licensing agreement, a Newark property sale-leaseback and a Tessenderlo Group equity investment are expected to generate about $1 billion for debt paydown.
$FMC Insider Trading Activity
$FMC insiders have traded $FMC stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $FMC stock by insiders over the last 6 months:
- MICHAEL F BARRY purchased 18,072 shares for an estimated $249,938
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$FMC Hedge Fund Activity
We have seen 200 institutional investors add shares of $FMC stock to their portfolio, and 217 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AQR CAPITAL MANAGEMENT LLC added 8,849,693 shares (+2147.5%) to their portfolio in Q1 2026, for an estimated $152,391,713
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC removed 3,314,440 shares (-62.7%) from their portfolio in Q1 2026, for an estimated $57,074,656
- MILLENNIUM MANAGEMENT LLC removed 1,745,911 shares (-61.0%) from their portfolio in Q1 2026, for an estimated $30,064,587
- TWO SIGMA INVESTMENTS, LP added 1,650,012 shares (+225.5%) to their portfolio in Q1 2026, for an estimated $28,413,206
- JANE STREET GROUP, LLC removed 1,582,880 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $27,257,193
- POINT72 ASSET MANAGEMENT, L.P. removed 1,318,373 shares (-76.1%) from their portfolio in Q1 2026, for an estimated $22,702,383
- GOLDMAN SACHS GROUP INC added 916,527 shares (+157.1%) to their portfolio in Q1 2026, for an estimated $15,782,594
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$FMC Congressional Stock Trading
Members of Congress have traded $FMC stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $FMC stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 07/10.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
